Sermorelin
Status unclearResearch-use peptide · also: geref, sermorelin acetate
A GHRH analog once sold as the approved product Geref (since discontinued); no currently marketed FDA-approved product.
People commonly track it for
Most often logged in a growth-hormone-support context (user intent, not a proven effect).
Evidence summary
Was FDA-approved as Geref; the FDA determined that product's withdrawal was not for safety or effectiveness reasons. It is generally supplied via compounding today (a claim described by non-FDA sources).
Regulation & source status
No currently marketed FDA-approved sermorelin product. Compounded availability is described by secondary sources, not confirmed by an FDA primary page.
Route considerations
Commonly discussed as an injectable in community settings. We don't provide route, preparation, or technique guidance — that's a clinician/pharmacist conversation.
Storage considerations
Often sold as a powder for reconstitution; unregulated products have no verified storage or stability data. Storage specifics belong to a pharmacist, not this profile.
Interaction & context review
Because human data is limited, interactions aren't well characterized. If you track it alongside other items or medications, review the full list with a clinician or pharmacist.
Sport / duty status
Prohibited in sport — WADA S2 (GHRH analog).
Track this item
You can log this as a custom peptide / medication-context item — record your own source status, route, storage note, and a schedule, and include it in an export for your clinician. StackWise doesn't add a dose.
Track this itemPeptide safety & source review
Sources
Source reviewed: 2026-07-23.